Trial intelligence / Profile preview

Alfacalcidol for Levator Ani Strength in Pelvic Organ Prolapse

NCT05505253Phase 3Completed

Sponsor
Universitas Padjadjaran
Start
Nov 2020
Primary completion
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of alfacalcidol in pelvic organ prolapse (POP), sponsored by Universitas Padjadjaran. Started Nov 2020; status: completed.

02

Drugs

alfacalcidol
03

Conditions

pelvic organ prolapse (POP)

Beyond the preview

Go deeper on NCT05505253.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05505253.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call